The latest update is out from Phio Pharmaceuticals (PHIO).
At the Company’s Annual Meeting, stockholders cast their votes on key proposals, resulting in the election of five directors for the next year, the ratification of BDO USA as the independent accounting firm, and the approval of a reverse stock split and an increase in common stock issuance under the 2020 Plan. All proposed actions received majority support, with specific voting results showing strong backing for directors and auditors, and a decisive mandate for the reverse stock split and plan amendment. The details of the reverse stock split will be finalized by the Board of Directors at a later date.
For a thorough assessment of PHIO stock, go to TipRanks’ Stock Analysis page.
